Growing community of inventors

Englewood, CO, United States of America

Dan Theodorescu

Average Co-Inventor Count = 4.90

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 9

Dan TheodorescuDavid B Ross (7 patents)Dan TheodorescuMichael Fitzpatrick Wempe (7 patents)Dan TheodorescuPhillip Reigan (7 patents)Dan TheodorescuChao Yan (4 patents)Dan TheodorescuSamy O Meroueh (3 patents)Dan TheodorescuMartin A Schwartz (3 patents)Dan TheodorescuRyan T Gill (1 patent)Dan TheodorescuPhilip Reigan (7 patents)Dan TheodorescuDavid Ross (2 patents)Dan TheodorescuKenneth Felsenstein (1 patent)Dan TheodorescuSamy Meroueh (1 patent)Dan TheodorescuDavid Ross (0 patent)Dan TheodorescuMichael Wempe (1 patent)Dan TheodorescuChao Yan (1 patent)Dan TheodorescuDan Theodorescu (8 patents)David B RossDavid B Ross (28 patents)Michael Fitzpatrick WempeMichael Fitzpatrick Wempe (14 patents)Phillip ReiganPhillip Reigan (7 patents)Chao YanChao Yan (4 patents)Samy O MerouehSamy O Meroueh (9 patents)Martin A SchwartzMartin A Schwartz (6 patents)Ryan T GillRyan T Gill (68 patents)Philip ReiganPhilip Reigan (7 patents)David RossDavid Ross (12 patents)Kenneth FelsensteinKenneth Felsenstein (1 patent)Samy MerouehSamy Meroueh (4 patents)David RossDavid Ross (0 patent)Michael WempeMichael Wempe (1 patent)Chao YanChao Yan (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. University of Colorado (7 from 1,381 patents)

2. University of Virginia Patent Foundation (2 from 998 patents)

3. Indiana University (2 from 769 patents)

4. Other (1 from 832,843 patents)


8 patents:

1. 12145962 - Construction and methods of use of a barcoded and gene edited DNA library

2. 11964985 - Anti-cancer compounds targeting Ral GTPases and methods of using the same

3. 11472812 - Anti-cancer compounds targeting Ral GTPases and methods of using the same

4. RE48557 - Anti-cancer compounds targeting Ral GTPases and methods of using the same

5. 10689392 - Anti-cancer compounds targeting ral GTPases and methods of using the same

6. 10676480 - Anti-cancer compounds targeting Ral GTPases and methods of using the same

7. 10202397 - Anti-cancer compounds targeting Ral GTPases and methods of using the same

8. 9353121 - Anti-cancer compounds targeting Ral GTPases and methods of using the same

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/28/2025
Loading…